Analysts Are Bullish on These NA Stocks: American Healthcare REIT, Inc. (AHR), CG Oncology, Inc. (CGON)
Confident Investing Starts Here:
American Healthcare REIT, Inc. (AHR)
RBC Capital analyst Michael Carroll maintained a Buy rating on American Healthcare REIT, Inc. on May 13 and set a price target of $39.00. The company's shares closed last Wednesday at $34.19.
According to TipRanks.com, Carroll is a 5-star analyst with an average return of 7.4% and a 59.6% success rate. Carroll covers the NA sector, focusing on stocks such as Easterly Government Properties, Diversified Healthcare Trust, and First Industrial Realty.
American Healthcare REIT, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $37.00, representing a 7.7% upside. In a report issued on April 28, Jefferies also initiated coverage with a Buy rating on the stock with a $37.00 price target.
CG Oncology, Inc. (CGON)
RBC Capital analyst Gregory Renza maintained a Buy rating on CG Oncology, Inc. on May 13 and set a price target of $68.00. The company's shares closed last Wednesday at $24.17, close to its 52-week low of $23.91.
According to TipRanks.com, Renza is a 4-star analyst with an average return of 7.7% and a 40.3% success rate. Renza covers the Healthcare sector, focusing on stocks such as Perspective Therapeutics, Verrica Pharmaceuticals, and ACADIA Pharmaceuticals.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CG Oncology, Inc. with a $60.25 average price target, implying a 150.1% upside from current levels. In a report issued on May 2, J.P. Morgan also initiated coverage with a Buy rating on the stock with a $41.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
MOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) — Heartflow, Inc. , the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare across all lines of business, including Commercial, Medicare Advantage, and Community plans. UnitedHealthcare is the first insurer to update its policies to cover Heartflow Plaque Analysis to fully align with the guidelines recently issued by radiology benefit manager EviCore. 'UnitedHealthcare's decision to cover Heartflow Plaque Analysis nationwide is a tremendous step in advancing patient access to our proven AI-driven plaque technology,' said John Farquhar, President and CEO of Heartflow. 'We are pleased that this major commercial payer recognizes the innovation and value that Heartflow's technology can provide to its members and healthcare providers in diagnosing and managing coronary artery disease. This decision will increase access for early detection and quantification of plaque using our precision Plaque Analysis tool, setting a new standard for cardiovascular care coverage.' The updated coverage will become effective October 1, 2025 for patients with acute or stable chest pain and mild-to-moderate narrowing of coronary arteries (1-70% stenosis) found on coronary computed tomography angiography (CCTA). Expanded access will allow for greater adoption of Heartflow Plaque Analysis for clinicians to incorporate into their diagnostic and patient management protocols, delivering more personalized treatment. Heartflow Plaque Analysis is the only FDA-cleared, AI-enabled, noninvasive plaque quantification tool with a reported 95% agreement with the gold standard, IVUS, in a prospective, global trial using blinded core lab adjudication.1 It is proven to change medical management in over half of patients beyond CCTA alone, helping physicians to improve outcomes.2 This coverage milestone follows the recent presentation of clinical outcomes from the DECIDE registry, which found management changes informed by Heartflow Plaque Analysis led to an average LDL cholesterol decrease of 18.7mg/dL.3 This clinically significant reduction is associated with an estimated 15% decrease in the risk of a cardiac event, highlighting the potential of Heartflow Plaque Analysis to improve patient outcomes by guiding more effective medical therapy and interventions.4 Heartflow is dedicated to transforming CAD from the leading cause of death to a disease that can be proactively managed for life. In the United States, CAD is estimated to be responsible for one heart attack every 40 seconds and one out of every five deaths.5 Heartflow has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population worldwide. About Heartflow, Inc. Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform — including Roadmap™ Analysis , FFR CT Analysis and Plaque Analysis — is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. Heartflow has helped clinicians manage over 400,000 patients worldwide. Discover how we're shaping the future of cardiovascular care at . Media Contact Elliot Levy [email protected]
Business Upturn
2 hours ago
- Business Upturn
Gray Announces Upsizing and Pricing of $775 Million of 7.250% Senior Secured First Lien Notes due 2033
ATLANTA, July 22, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. ('Gray') (NYSE: GTN) announced today the pricing of its previously announced private offering of $775 million aggregate principal amount of 7.250% senior secured first lien notes due 2033 (the 'Notes'). This represents an increase of $75 million over the amount previously announced. The Notes were priced at 100% of par. The offering of the Notes is expected to close on July 25, 2025, subject to customary closing conditions. The Notes are being offered to (i) repay a portion of Gray's term loan D due December 1, 2028, (ii) repay a portion of Gray's term loan F due June 4, 2029, (iii) repay all outstanding indebtedness drawn under Gray's revolving credit facility, (iv) pay fees and expenses in connection with the offering, and (v) for general corporate purposes. The Notes will be guaranteed, jointly and severally, on a senior secured first lien basis, by each existing and future restricted subsidiary of Gray that guarantees Gray's existing senior credit facility. The Notes and related guarantees will be offered only to persons reasonably believed to be qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended (the 'Securities Act'), and to non-U.S. persons in transactions outside the United States under Regulation S of the Securities Act. The Notes have not been, and will not be, registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This notice is being issued pursuant to and in accordance with Rule 135c under the Securities Act. Forward-Looking Statements: This press release contains certain forward-looking statements that are based largely on Gray's current expectations and reflect various estimates and assumptions by Gray. These statements are statements other than those of historical fact and may be identified by words such as 'estimates,' 'expect,' 'anticipate,' 'will,' 'implied,' 'intend,' 'assume' and similar expressions. Forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such forward-looking statements. Such risks, trends and uncertainties, which in some instances are beyond Gray's control, include Gray's ability to consummate the offering of notes; the intended use of proceeds of the offering; and other future events. Gray is subject to additional risks and uncertainties described in Gray's quarterly and annual reports filed with the Securities and Exchange Commission from time to time, including in the 'Risk Factors,' and management's discussion and analysis of financial condition and results of operations sections contained therein, which reports are made publicly available via its website, Any forward-looking statements in this communication should be evaluated in light of these important risk factors. This press release reflects management's views as of the date hereof. Except to the extent required by applicable law, Gray undertakes no obligation to update or revise any information contained in this communication beyond the date hereof, whether as a result of new information, future events or otherwise. Gray Contacts: Jeffrey R. Gignac, Executive Vice President and Chief Financial Officer, 404-504-9828 Kevin P. Latek, Executive Vice President, Chief Legal and Development Officer, 404-266-8333 # # # Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
2 hours ago
- Business Upturn
MDWerks' Two Trees Beverage Subsidiary to Install New Spirits Rapid Aging System
GREEN COVE SPRINGS, Fla., July 22, 2025 (GLOBE NEWSWIRE) — MDWerks, Inc. ('MDWerks' or the 'Company') (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that its subsidiary, Two Trees Beverage Company ('Two Trees'), is planning to install a second Spirits Rapid Aging System ('SRAS') at its Fletcher, North Carolina facilities in August 2025 due to steady demand and projected growth potential. The new, larger SRAS unit, which is in the final stage of construction, will augment an existing SRAS unit to accommodate strong built-in demand for Two Trees' aged white-label distillates and award-winning spirits portfolio. MDWerks' subsidiary, RF Specialties, LLC, is designing and building the new SRAS unit, which is expected to approximately quintuple spirits production capacity at the Two Trees facility. Steven Laker, Chief Executive Officer of MDWerks, commented, 'Customer demand for Two Trees' aged white-label distillates and award-winning spirits brands has vastly exceeded peak throughput of our existing spirits rapid aging system, which has been running at or near full capacity since May 2025. We are deploying a second, larger SRAS unit at Two Trees' facilities in August 2025, which will provide approximately five times more capacity to meet built-in demand from several customers for various white-label products, including single malts, whiskeys, rums, and bourbons. Simultaneously, Two Trees' branded sales continue to grow organically, driven by expanded distribution, enhanced marketing and successful new product launches.' Mr. Laker added, 'Our Whiskey-as-a-Service business model continues to gain traction. Under contracts that we previously announced in February 2025, we are building three SRAS units. The first unit is scheduled to be installed at the facilities of one of the largest distilleries in the U.S. in the fourth quarter of 2025 and we expect to deliver a second SRAS unit to this customer in the first quarter of 2026. Additionally, we anticipate deploying the third SRAS unit at the facilities of a U.S. broker of bulk spirits in the first half of 2026. Multiple other conversations are underway with industry participants who recognize the substantial economic and environmental benefits of our proprietary spirits rapid aging technology.' SRAS Overview The Company's SRAS units leverage patented molecular energy wave technology that swiftly and sustainably transforms distillate to maturity, delivering traditional taste profiles in a fraction of the time (weeks vs. years) without sacrificing quality and with greatly reduced environmental impact and cost. Versus traditional aging methods, the Company's SRAS units deliver the following benefits: Award-winning quality and consistency Better economics Less wood consumption (~90% less) Less storage space (barrel housing) Less energy consumption Greater innovation Faster speed to market Lower carbon footprint About MDWerks, Inc. MDWerks, Inc. ('MDWerks') (OTCQB: MDWK) is a forward-thinking company that is leading the charge in the world of sustainable technology. As a prominent provider of energy wave technologies, MDWerks is committed to developing innovative solutions that help businesses reduce their costs and drive business value. For more information, please visit MDWerks' wholly owned subsidiary, Two Trees Beverage Company, is headquartered deep in the Appalachian Mountain country, creating fine spirits, aged sustainably. Two Trees' fine spirits brands, including Two Trees ® and Tim Smith Spirits ® , have received multiple industry awards. For more information, please visit MDWerks' wholly owned subsidiary, RF Specialties, LLC ('RFS'), addresses companies' most pressing challenges by implementing automated radio frequency technology systems in a sustainable way reducing costs and increasing speed to market when compared to traditional methods. For more information, please visit Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements'. Forward-looking statements also may be included in other publicly available documents issued by MDWK and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as 'anticipate,' 'intend,' 'plan,' 'goal,' 'seek,' 'believe,' 'project,' 'estimate,' 'expect,' 'strategy,' 'future,' 'likely,' 'may,' 'should,' 'would,' 'could,' 'will' and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause MDWK's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for MDWK's products and services, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the Securities and Exchange Commission from time to time, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K, which are available on the Securities and Exchange Commission's website at We assume no obligation to update any forward-looking statements contained in this press release. Company Contact:MDWerks, Inc. Steven LakerT: (252) 501-0019 [email protected]
